RYCKX Mutual Fund

RYCKX Mutual Fund

NAV$44.65
See how much of RYCKX you already own
Just $25 once·$69/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Mar 31, 2026

Net Assets
$123,493.02
Expense Ratio
2.29%
Dividend Yield (Current)
-
Holdings
97
Inception Date
Feb 20, 2004
Fund Family
Guggenheim Investments
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+12.27%
1 Year+15.87%
3 Year+11.56%
5 Year+4.11%
10 Year+7.29%

Asset Allocation

Stocks: 99.66%
Bonds: 0.34%
See how much of RYCKX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report is $25, once. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
FTITECHNIPFMC PLC COMMON STOCK1.78%
VALValaris Plc1.77%
ARWRArrowhead Pharmaceuticals Inc1.57%
WWDWoodward Inc1.54%
MTZMastec Inc1.49%
Top 10 Concentration: 15.23%Report Date: Mar 31, 2026
Download all 97 holdings for RYCKX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Frequency
Annually
Latest Distribution
$6.63
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

RYCKX Mutual Fund Overview

RYCKX Mutual Fund (S&P MidCap 400 Pure Growth Fund Class C) is managed by Guggenheim Investments with $123,493.02 in net assets. RYCKX expense ratio is 2.29%, holding 97 positions across sectors including Health Care, Industrials, Information Technology. Inception date: 2004-02-20.

RYCKX performance shows a YTD return of 12.27%. The 1-year return is 15.87% and the 5-year return is 4.11%.

RYCKX top holdings include TECHNIPFMC PLC COMMON STOCK (1.8%), Valaris Plc (1.8%), Arrowhead Pharmaceuticals Inc (1.6%), Woodward Inc (1.5%), Mastec Inc (1.5%). Go to all RYCKX holdings, RYCKX sectors, or RYCKX dividends.

RYCKX can be compared against other funds. Use RYCKX overlap to find shared positions, or RYCKX vs another fund for a side-by-side view. RYCKX alternatives are available via the screener, along with tax-loss harvesting opportunities.